Creo Medical – executive interview with Craig Gulliford, CEO

Creo Medical – executive interview with Craig Gulliford, CEO

Creo Medical — 3 videos in collection

More on this equity

Creo Medical is a UK medical device company developing minimally invasive endoscopic electrosurgical tools across its proprietary Kamaptive technology to optimise surgical outcomes. The company has developed and commercialised CE-marked devices, with five cleared by the FDA to date. These tools are complemented by Creo’s fully integrated acquisition of Albyn Medical (acquired in 2020), a profitable consumables company supported by a direct salesforce in Europe.


You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free